258 related articles for article (PubMed ID: 35542976)
1. A clinical and laboratory-based nomogram for predicting nonalcoholic fatty liver disease in non-diabetic adults: a cross-sectional study.
Qian Y; Sun B; Zhang Y; Zhang M; Jiao X; Lai L; Yang W
Ann Palliat Med; 2022 Jul; 11(7):2349-2359. PubMed ID: 35542976
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
[TBL] [Abstract][Full Text] [Related]
3. Nomogram for predicting the risk of nonalcoholic fatty liver disease in older adults in Qingdao, China: A cross-sectional study.
Wang Z; Cui J; Li X; Gao R; Feng E; Luo G; Guo B; Wu H; Sun Y; Sun J
Asia Pac J Clin Nutr; 2024 Mar; 33(1):83-93. PubMed ID: 38494690
[TBL] [Abstract][Full Text] [Related]
4. A Prediction Model Based on Noninvasive Indicators to Predict the 8-Year Incidence of Type 2 Diabetes in Patients with Nonalcoholic Fatty Liver Disease: A Population-Based Retrospective Cohort Study.
Cai X; Zhu Q; Cao Y; Liu S; Wang M; Wu T; Hong J; Ahmat A; Aierken X; Li N
Biomed Res Int; 2021; 2021():5527460. PubMed ID: 34095297
[TBL] [Abstract][Full Text] [Related]
5. A Prediction Model of the Incidence of Nonalcoholic Fatty Liver Disease With Visceral Fatty Obesity: A General Population-Based Study.
Zhou Y; Chai X; Guo T; Pu Y; Zeng M; Zhong A; Yang G; Cai J
Front Public Health; 2022; 10():895045. PubMed ID: 35812496
[TBL] [Abstract][Full Text] [Related]
6. A nomogram incorporated lifestyle indicators for predicting nonalcoholic fatty liver disease.
Peng K; Wang S; Gao L; You H
Medicine (Baltimore); 2021 Jul; 100(26):e26415. PubMed ID: 34190160
[TBL] [Abstract][Full Text] [Related]
7. A Nomogram Model Based on Noninvasive Bioindicators to Predict 3-Year Risk of Nonalcoholic Fatty Liver in Nonobese Mainland Chinese: A Prospective Cohort Study.
Cai X; Aierken X; Ahmat A; Cao Y; Zhu Q; Wu T; Li N
Biomed Res Int; 2020; 2020():8852198. PubMed ID: 33204721
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic fatty liver disease risk prediction model and health management strategies for older Chinese adults: a cross-sectional study.
Pan H; Liu B; Luo X; Shen X; Sun J; Zhang A
Lipids Health Dis; 2023 Nov; 22(1):205. PubMed ID: 38007441
[TBL] [Abstract][Full Text] [Related]
9. Development and application of a novel model to predict the risk of non-alcoholic fatty liver disease among lean pre-diabetics with normal blood lipid levels.
Zhu W; Shi P; Fu J; Liang A; Zheng T; Wu X; Yuan S
Lipids Health Dis; 2022 Dec; 21(1):149. PubMed ID: 36585668
[TBL] [Abstract][Full Text] [Related]
10. Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.
Li XD; Qiu BH; Su FC; Sun SX
Clin Exp Hypertens; 2016; 38(7):639-643. PubMed ID: 27680771
[TBL] [Abstract][Full Text] [Related]
11. LASSO-derived model for the prediction of lean-non-alcoholic fatty liver disease in examinees attending a routine health check-up.
Hsu CL; Wu PC; Wu FZ; Yu HC
Ann Med; 2024 Dec; 56(1):2317348. PubMed ID: 38364216
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of an online dynamic nomogram based on the atherogenic index of plasma to screen nonalcoholic fatty liver disease.
Peng H; Zhang J; Huang X; Xu M; Huang J; Wu Y; Peng XE
Lipids Health Dis; 2023 Mar; 22(1):44. PubMed ID: 36991386
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a Risk Prediction Model for Non-alcoholic Fatty Liver Disease in Type 2 Diabetes.
Zhang Y; Shi R; Yu L; Ji L; Li M; Hu F
Diabetes Ther; 2020 Sep; 11(9):2057-2073. PubMed ID: 32725485
[TBL] [Abstract][Full Text] [Related]
14. Evaluating future risk of NAFLD in adolescents: a prediction and decision curve analysis.
Abeysekera KWM; Orr JG; Gordon FH; Howe LD; Hamilton-Shield J; Heron J; Hickman M
BMC Gastroenterol; 2022 Jun; 22(1):323. PubMed ID: 35773644
[TBL] [Abstract][Full Text] [Related]
15. Risk Prediction for Non-alcoholic Fatty Liver Disease Based on Biochemical and Dietary Variables in a Chinese Han Population.
Pan X; Xie X; Peng H; Cai X; Li H; Hong Q; Wu Y; Lin X; Xu S; Peng XE
Front Public Health; 2020; 8():220. PubMed ID: 32714888
[TBL] [Abstract][Full Text] [Related]
16. SFI, a sex hormone binding globulin based nomogram for predicting non-alcoholic fatty liver disease in the Chinese population.
Hua X; Zhang H; Yang W; Liu G; Zhang S; Wang Y
Front Endocrinol (Lausanne); 2023; 14():1176019. PubMed ID: 37334312
[TBL] [Abstract][Full Text] [Related]
17. Clinical spectrum transition and prediction model of nonalcoholic fatty liver disease in children with obesity.
Zhou X; Lin X; Chen J; Pu J; Wu W; Wu Z; Lin H; Huang K; Zhang L; Dai Y; Ni Y; Dong G; Fu J
Front Endocrinol (Lausanne); 2022; 13():986841. PubMed ID: 36120457
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a noninvasive clinical scoring system to predict significant fibrosis in patients with nonalcoholic fatty liver disease.
Jin W; Xu Y; Zhu W; Xia Z; Wu J
Clin Chim Acta; 2021 Mar; 514():48-53. PubMed ID: 33333040
[TBL] [Abstract][Full Text] [Related]
19. Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD.
Bazick J; Donithan M; Neuschwander-Tetri BA; Kleiner D; Brunt EM; Wilson L; Doo E; Lavine J; Tonascia J; Loomba R
Diabetes Care; 2015 Jul; 38(7):1347-55. PubMed ID: 25887357
[TBL] [Abstract][Full Text] [Related]
20. Individualized risk prediction of significant fibrosis in non-alcoholic fatty liver disease using a novel nomogram.
Zhou YJ; Ye FZ; Li YY; Pan XY; Chen YX; Wu XX; Xiong JJ; Liu WY; Xu SH; Chen YP; Zheng MH
United European Gastroenterol J; 2019 Oct; 7(8):1124-1134. PubMed ID: 31662869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]